This episode of Lung Cancer Considered covers highlights from the 2025 ESMO Annual Meeting held October 17th to the 21st in Berlin, Germany.

Guests are:

Dr. Xiuning Le from MD Anderson Cancer Center in Houston, Texas.

Dr. Pedro Rocha from Vall d’Hebron University Hospital in Barcelona, Spain.

Dr. Riyaz Shah, a consultant medical oncologist at the Kent Oncology Centre in the United Kingdom.

In this episode of Lung Cancer Considered, Dr. Narjust Florez leads a discussion with Ann Fish-Steagall and Amanda Nerstad about the 2025 Lung Cancer Hope Summit. The team discusses highlights from the meeting, including groundbreaking research, innovative treatments, and patient advocacy.

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages.

In this episode, host Dr. Helena Linardou moderates a discussion in Greek about highlights from the conference with Dr. Foteinos-Ioannis Dimitrakopoulos and Dr. Evangelos Sarris.

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive stage small cell lung cancer, based on the phase III IMforte trial. Dr. Hossein Borghaei joins the podcast to explain the results and offer perspective on the impact of maintenance therapy for SCLC.

Guest:

Dr. Hossein Borghaei, DO, MS

Chief, Division of Thoracic Medical Oncology

Professor, Department of Hematology/Oncology

Fox Chase Cancer Center

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages.

In this episode, host Dr. Nagla Abdel Karim moderates a discussion in Arabic about highlights from the conference with Dr. Riad Abdeljalil, Dr. Khaled Abdel Aziz, Dr. Ashraf Abdel Ghani, Dr. Ahmed Rabea, and Dr. Hussein Soudy.

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Lizza Hendriks moderates a discussion in Dutch with Dr. Marthe Paats and Dr. Gerrina Ruiter on the treatment of EGFR non-small cell lung cancer.

Lung Cancer Considered: Targeting EGFR NSCLC by IASLC

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages.

In this episode, host Dr. Misako Nagasaka moderates a discussion in Japanese about highlights from the conference with Dr. Hidehito Horinouchi.

Key Topics Covered:

• WCLC 2025 highlights

• FLAURA2

• HARMONi

The 2025 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2025 in world languages. In this episode, host Dr. Chul Kim moderates a discussion in Korean about highlights from the conference with Dr. Jeongmin Seo and Dr. Min Hee Hong.

Guest Host:

Chul Kim, MD, MPH

Thoracic Medical Oncologist and Associate Professor

Georgetown University

Instagram: @fe0120

Guest Name(s) & Title(s):

Jeongmin Seo, MD, MSc

Assistant Professor, Medical Oncology

Seoul National University Bundang Hospital

Min Hee Hong, MD

Associate Professor, Yonsei Cancer Center

Severance Hospital, Seoul

This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a discussion of the formulation and its place in the management of patients with lung cancer.

Guests:

Cheryl Ho, MD, FRCPC

Thoracic Oncologist, BC Cancer

Clinical Associate Professor and Fellowship Program Director

University of British Columbia

Maria Velez Velez, MD, MS

Clinical Instructor, Division of Hematology/Oncology

David Geffen School of Medicine at UCLA